Latest News

Business

  • Mahindra renames electric car amid IndiGo's trademark challenge, says will contest the brand rights in court
    on December 7, 2024 at 9:31 AM

    Mahindra announced it will challenge the brand rights of "6E" in court after IndiGo raised concerns over the name of its electric SUV, BE 6e. Mahindra clarified that its trademark application for "BE 6e" under class 12 (vehicles) is distinct from IndiGo's "6E," which represents an airline, and therefore poses no risk of confusion.

  • Samvardhana Motherson to acquire 95% stake in Japan's Atsumitec for USD 57 mn
    on December 6, 2024 at 9:32 AM

    Samvardhana Motherson International will acquire a 95% stake in Japan-based Atsumitec for USD 57 million (around Rs 482 crore). The acquisition will be made through its subsidiary, Samvardhana Motherson Automotive Systems Group BV. Honda Motor will retain the remaining 5% voting rights.

  • Acre ARC wins bid to take over Essel Groups' bad loans
    on December 5, 2024 at 6:27 PM

    Acre ARC, backed by Ares SSG, has won bids to acquire ₹1,350 crore of debt from Essel Group and ₹2,613 crore of retail and SME loans from JC Flowers ARC. Acre's ₹505 crore bid secured the Essel Group's non-performing loans, while a ₹237 crore bid won the retail and SME portfolio.

  • India Inc mostly keeps corruption, bribery cases behind closed doors
    on December 5, 2024 at 6:00 PM

    Indian companies rarely report bribery cases, despite anti-corruption policies. Public sector companies disclose more incidents due to higher scrutiny. This is because they handle public funds and large contracts. Private companies prefer internal handling of such issues. Unlike the US and UK, India lacks incentives for self-reporting corruption.

  • Presenting the jury for The Economic Times Awards for Corporate Excellence
    on December 5, 2024 at 6:09 AM

    Meet the high-powered jury that will pick the winners of India Inc’s most prestigious awards: The Economic Times Awards for Corporate Excellence.

Global News

    Feed has no items.

Wealth

    Feed has no items.

Economy

    Feed has no items.

Healthcare

  • Suven Pharma to acquire 56 pc stake in US-based firm for USD 64.4 mn
    on December 7, 2024 at 11:01 AM

    Suven Pharmaceuticals will acquire a 56% stake in US-based NJ Bio Inc for USD 64.4 million. This acquisition aligns with Suven's goal of becoming a leading technology-driven CDMO, specializing in antibody-drug conjugates (ADCs). NJ Bio's expertise and client base will boost Suven's presence in the rapidly expanding ADC/XDC market.

  • Laurus Labs biotech unit raises Rs 120 crore from Eight Roads Ventures
    on December 6, 2024 at 12:40 PM

    Laurus Bio has secured ₹120 crore in equity investment from Eight Roads Ventures and F-Prime Capital, with Laurus Labs co-investing ₹40 crore. This funding will expand Laurus Bio's fermentation-based manufacturing to meet growing demand for its animal-free proteins and growth factors used in various industries.

  • A comprehensive approach to diabetes care
    on December 6, 2024 at 4:30 AM

    India faces a significant diabetes challenge, with high prevalence, underdiagnosis, and poor control contributing to early complications and cardiovascular risks. Aggressive screening, lifestyle changes, and individualized treatment plans are crucial for effective diabetes management and improved health outcomes.

  • Dr Reddy's unit gets penalty of Rs 28.7 lakh from Kazakhstan authority
    on December 5, 2024 at 2:31 PM

    Dr. Reddy's Laboratories' Kazakhstan subsidiary has been fined Rs 28.7 lakh (KZT 17,597,212) by the Kazakhstani tax authorities. The penalty is for disallowed expenses claimed in 2021. Dr. Reddy's stated the penalty will not materially impact its financials or operations.

  • Aurobindo unit gets USFDA nod for generic cancer drug
    on December 5, 2024 at 11:26 AM

    Aurobindo Pharma's subsidiary, Eugia Pharma, gets USFDA nod for cancer drug Pazopanib. The drug treats renal cell carcinoma and soft tissue sarcoma. Launch expected in Q4FY25. The market size is estimated at USD 106 million. Aurobindo's shares closed slightly lower on Thursday. The drug is a generic version of Novartis's Votrient.

Technology

  • Trump's crypto team takes shape but questions remain over who will drive policy
    on December 7, 2024 at 10:30 AM

    Crypto executives cheered the news and welcomed the new team, saying the pair would end the Biden administration's crackdown and promote innovation. But some Washington analysts said the creation of a crypto czar, a new role, sowed ambiguity over who would drive crypto policy and flagged the potential for policy clashes.

  • 'It's for real this time': TikTok creators react to potential ban
    on December 7, 2024 at 7:45 AM

    While TikTok argued that the law unfairly singled out the company and that a ban would infringe on the free speech rights of American users, the judges said that the law was "carefully crafted to deal with only control by a foreign adversary," and that it did not run afoul of the First Amendment. The ruling acknowledged that Americans would "lose access to an outlet for expression, a source of community and even a means of income," but that Congress weighed those risks against national security concerns.

  • US panel urges greater crypto asset regulation
    on December 7, 2024 at 6:02 AM

    On Friday, the Financial Stability Oversight Council (FSOC) recommended that Congress pass legislation "providing federal financial regulators with explicit rulemaking authority over the spot market for crypto assets that are not securities." It also urged lawmakers to approve rules creating a federal framework for stablecoin issuers.

  • US AI task force co-chair asks FERC to support co-located data centers
    on December 7, 2024 at 5:03 AM

    Last month, FERC rejected in a 2-1 vote a request to increase the capacity of an Amazon data center located on the site of a Talen Energy nuclear power plant in Pennsylvania, after raising questions about how diverting nuclear electricity to serve the center would affect the broader grid.

  • Amazon hit with US consumer lawsuit over 'excluded' fast delivery zones
    on December 7, 2024 at 4:21 AM

    The lawsuit parallels a case that Washington, D.C.'s attorney general filed earlier this week accusing Amazon of violating the city's consumer protection provisions. Amazon in a statement said the claims were "categorically false." Amazon said it made a business decision to adjust operations in the affected zip codes for the safety of the company's drivers.